2025.02.0509:14:00UTC+00European Shares Subdued As Tech Stocks Decline After AMD Earnings

On Wednesday, European equities saw a modest decline, primarily influenced by a downturn in technology stocks, although this was somewhat balanced by gains in the healthcare and financial sectors.

In terms of economic developments, S&P Global reported an increase in private sector activity within the eurozone for January. The composite Purchasing Managers' Index (PMI) saw a slight rise, moving from 49.6 in December to 50.2.

The broad STOXX 600 index of European shares edged down by 0.1 percent to 535.45, following a 0.2 percent increase on Tuesday. The German DAX fell by 0.5 percent, France's CAC 40 decreased by 0.3 percent, and the U.K.'s FTSE 100 remained mostly flat.

Among technology firms, ASML Holding slipped by 1.1 percent and Infineon Technologies declined by 0.9 percent, following Advanced Micro Devices' disappointing 2024 data center sales figures.

Conversely, Future Plc, a U.K. publishing firm, climbed over 2 percent in London after it reiterated its financial guidance for FY25. Meanwhile, GSK saw a significant increase, soaring over 6 percent, after the pharmaceutical company reported strong performance for 2024 and upgraded its long-term sales projections.

Vestas, the wind turbine manufacturer, experienced a 2.5 percent drop after it flagged continued uncertainty for 2025. In the energy sector, TotalEnergies, the French oil giant, rose 1.3 percent after it announced an increase in dividends and continued share buybacks, despite a fall in fourth-quarter earnings.

Credit Agricole, the French banking group, gained 2.1 percent following better-than-expected earnings, driven by higher revenue in the last quarter of 2024. Spanish bank Banco Santander saw a notable rise of 7.3 percent as its 2024 attributable profit grew by 14 percent compared to the prior year.

In the jewelry sector, Danish company Pandora dropped by 1.5 percent after issuing a warning that this year's organic growth would not match last year's levels. On a brighter note, pharmaceutical heavyweight Novo Nordisk surged nearly 4 percent after reporting fourth-quarter earnings that surpassed analysts' expectations.